DE60307082D1 - PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE - Google Patents

PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE

Info

Publication number
DE60307082D1
DE60307082D1 DE60307082A DE60307082A DE60307082D1 DE 60307082 D1 DE60307082 D1 DE 60307082D1 DE 60307082 A DE60307082 A DE 60307082A DE 60307082 A DE60307082 A DE 60307082A DE 60307082 D1 DE60307082 D1 DE 60307082D1
Authority
DE
Germany
Prior art keywords
desmopressin
dispersible
pharmaceutical composition
mouth valve
mouth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60307082A
Other languages
German (de)
Other versions
DE60307082T2 (en
DE60307082T4 (en
Inventor
Anders Nilsson
Hans Lindner
Jorgen Wittendorff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0210397.6A external-priority patent/GB0210397D0/en
Application filed by Ferring BV filed Critical Ferring BV
Application granted granted Critical
Publication of DE60307082D1 publication Critical patent/DE60307082D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60307082A 2002-05-07 2003-05-07 PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE Expired - Lifetime DE60307082D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0210397.6A GB0210397D0 (en) 2002-05-07 2002-05-07 Pharmaceutical formulations
PCT/IB2002/004036 WO2003094885A1 (en) 2002-05-07 2002-09-20 Sublingual pharmaceutical formulation of desmopressin
PCT/IB2003/002368 WO2003094886A2 (en) 2002-05-07 2003-05-07 Desmopressin in an orodispersible dosage form

Publications (1)

Publication Number Publication Date
DE60307082D1 true DE60307082D1 (en) 2006-09-07

Family

ID=29422105

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2003607082 Expired - Lifetime DE60307082T4 (en) 2002-05-07 2003-05-07 PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE
DE60307082A Expired - Lifetime DE60307082D1 (en) 2002-05-07 2003-05-07 PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2003607082 Expired - Lifetime DE60307082T4 (en) 2002-05-07 2003-05-07 PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE

Country Status (10)

Country Link
JP (1) JP2006502972A (en)
AU (1) AU2003233118B8 (en)
BR (1) BR0309819A (en)
CA (1) CA2484724C (en)
DE (2) DE60307082T4 (en)
HR (1) HRP20041152B1 (en)
NO (1) NO335167B1 (en)
NZ (1) NZ535861A (en)
PT (1) PT1501534E (en)
WO (1) WO2003094886A2 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
JP4523265B2 (en) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 Orally disintegrating preparations for the treatment of urination disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
PT1500390E (en) 2003-07-25 2005-10-31 Ferring Bv PHARMACEUTICAL COMPOSITION AS A SOLID DOSAGE FORM AND METHOD OF PRODUCTION
CN1878563A (en) * 2003-11-10 2006-12-13 西摩·H·费恩 Pharmaceutical compositions including low dosages of desmopressin
DK1530967T3 (en) 2003-11-13 2006-07-03 Ferring Bv Blister pack and associated solid dosage form
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
PT1550439E (en) * 2003-12-29 2006-06-30 Ferring Bv METHOD FOR PREPARING A SOLID FORM OF DESMOPRESSIN DOSAGE
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
GB0406048D0 (en) * 2004-03-18 2004-04-21 Ardana Bioscience Ltd Drug formulations
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
CA2584456C (en) * 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
SE528446C2 (en) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Pharmaceutical composition comprising desmopressin, silica and starch
ES2382982T3 (en) 2007-07-21 2012-06-15 Albany Molecular Research, Inc. Indazoles substituted with 5-pyridinone and pharmaceutical compositions thereof
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
EP2674417A3 (en) 2007-11-21 2014-04-09 Decode Genetics EHF Biaryl PDE4 inhibitors for treating inflammation
EP2240481A1 (en) 2008-01-11 2010-10-20 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as mch antagonists
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
LT3225249T (en) * 2008-05-21 2019-01-10 Ferring B.V. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
KR101675174B1 (en) 2009-01-26 2016-11-10 이스라엘 인스티튜트 포 바이올로지컬 리서치 Bicyclic heterocyclic spiro compounds
TWI471127B (en) 2009-04-29 2015-02-01 Intervet Int Bv A process for preparing an orally disintegrating tablet for human use, an orally disintegrating tablet thus obtained and a package containing the orally disintegrating tablet
TWI468157B (en) * 2009-04-29 2015-01-11 Intervet Int Bv Process to form a tablet, system for performing this process and package comprising the tablet
ES2929471T3 (en) 2009-06-18 2022-11-29 Acerus Pharmaceuticals Usa Llc Safe administration of desmopressin
MX2012000572A (en) 2009-07-14 2012-05-08 Albany Molecular Res Inc 5-ht3 receptor modulators, methods of making, and use thereof.
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
JP5736031B2 (en) 2010-03-29 2015-06-17 フェリング ベスローテン フェンノートシャップ Fast-dissolving pharmaceutical composition
JO3112B1 (en) 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
BR112013009255B1 (en) * 2010-10-08 2021-02-23 R.P. Scherer Technologies, Llc solid composition of rapid dissolving oral vaccine
JP2011116764A (en) * 2011-02-08 2011-06-16 Fine Seymour H Medical composition containing low dose desmopressin
JP6174585B2 (en) 2011-09-16 2017-08-02 フェリング ベスローテン フェンノートシャップ Fast dissolving pharmaceutical composition
JP5928159B2 (en) * 2012-05-28 2016-06-01 ニプロ株式会社 Pharmaceutical composition
TW201422254A (en) * 2012-11-21 2014-06-16 Ferring Bv Composition for immediate and extended release
CN103993061B (en) * 2014-05-20 2018-03-23 海南美合泰生物科技有限公司 A kind of production method of Isin glue collagen
KR20150144209A (en) * 2014-06-16 2015-12-24 훼링 비.브이. Pharmaceutical composition comprising stabilized desmopressin or pharmaceutically acceptable salt thereof
JP6341777B2 (en) * 2014-06-30 2018-06-13 リプリーズ バイオファーマシューティクス,エルエルシー Pharmaceutical composition containing low dose desmopressin
BR112019010949A2 (en) 2017-01-11 2019-10-01 Ferring Bv fast disintegrating pharmaceutical composition
DE102017104472A1 (en) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Orodispersible tablet containing burlulipase and pharmaceutical composition prepared therefrom
JP2021518413A (en) 2018-03-20 2021-08-02 アイカーン スクール オブ メディシン アット マウント サイナイ Kinase inhibitor compounds and compositions and usage
CA3124700A1 (en) 2018-12-31 2020-07-09 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use
WO2024143501A1 (en) * 2022-12-28 2024-07-04 中外製薬株式会社 Solid dispersion containing substance to be dispersed, pharmaceutical composition containing same, and production methods therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
JP3253127B2 (en) * 1991-06-07 2002-02-04 帝國製薬株式会社 Preparation containing bioactive polypeptide
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
EP1146800A1 (en) * 1999-01-27 2001-10-24 Spenco Medical Corporation Therapeutic magnetic insoles
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions

Also Published As

Publication number Publication date
JP2006502972A (en) 2006-01-26
NO335167B1 (en) 2014-10-06
DE60307082T2 (en) 2007-01-18
AU2003233118A1 (en) 2003-11-11
WO2003094886A2 (en) 2003-11-20
PT1501534E (en) 2006-09-29
BR0309819A (en) 2005-03-01
CA2484724A1 (en) 2003-11-20
WO2003094886A3 (en) 2004-07-22
NO20045345L (en) 2005-02-07
HRP20041152A2 (en) 2005-04-30
DE60307082T4 (en) 2015-04-30
AU2003233118B8 (en) 2009-07-30
HRP20041152B1 (en) 2008-01-31
AU2003233118B2 (en) 2006-10-26
NZ535861A (en) 2006-11-30
CA2484724C (en) 2007-01-16

Similar Documents

Publication Publication Date Title
DE60307082D1 (en) PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE
DE60304993D1 (en) DISPERSIBLE PHARMACEUTICAL COMPOSITION WITH AGOMELATIN IN THE MOUTH VALVE
PL1919894T3 (en) Novel polyquinoline derivatives and the therapeutic use thereof
EP1824467A4 (en) Apogossypolone and the uses thereof
IL182947A0 (en) Chimeric polypeptides and pharmaceutical compositions containing the same
EP1715882A4 (en) Smac peptidomimetics and the uses thereof
DE502006005914D1 (en) SEN IN THE BODY'S INSIDE
EP1723408A4 (en) Nanowire light sensor and kit with the same
EP1781114A4 (en) Barrier compositions and articles produced with the compositions
ZA200706254B (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
GB2396016B (en) J-spectroscopy in the wellbore
IL186102A0 (en) Alpha ketoamide derivatives and pharmaceutical compositions containing the same
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
AP2005003420A0 (en) Acidic composition and its uses.
BR0301351B1 (en) Ball valve with flowmeter incorporated directly into the balls.
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
DE60310526D1 (en) IVABRADINE-CONTAINING PHARMACEUTICAL COMPOSITION WITH ORAL DISPERSION
FI20011074A (en) Foundation in the watershed
HK1075272A1 (en) Dye composition and the use thereof
HK1073664A1 (en) Dye compositions and the use thereof
DE60305642D1 (en) DISPERSIBLE PHARMACEUTICAL COMPOSITION WITH PIRIBEDIL IN THE MOUTH VALVE
GB0312340D0 (en) Improved game and aricle for use with the game
GB0323138D0 (en) Pyrimidines substituted in the 2,4,6 positions and their different uses
ITTO20060204A1 (en) COLLECTORS, IN PARTICULAR, STACKABLE AND INSERTABLE THE ONE INSIDE THE OTHER
FI20045309A (en) Method and arrangement in the coating line

Legal Events

Date Code Title Description
8364 No opposition during term of opposition